Ειδήσεις: RARE DISEASES | PXAI

22/04 01:45 statnews.com

STAT+: Kyverna Therapeutics plans to submit cell therapy for stiff person syndrome for FDA approval

BIOTECHNOLOGY DRUG DEVELOPMENT BIOTECH RARE DISEASES CRIME POLITICS

20/04 11:30 statnews.com

Opinion: Measles outbreak means my immunocompromised son can’t leave the house without extreme safety measures

RARE DISEASES POLITICS INFECTIOUS DISEASE FIRST OPINION HEALTH CHILDREN'S HEALTH

14/04 11:30 statnews.com

Opinion: My brother can’t access a just-approved breakthrough drug for his rare disease

BIOTECH POLITICS RARE DISEASES FDA FIRST OPINION

02/04 11:26 defenseworld.net

SCYNEXIS Pivots to ADPKD, Acquires AMPK Activator SCY-770 and Extends Cash Runway to 2029

SCYNEXIS ADPKD SCY‑770 AMPK activator Phase 2 corporate strategy

31/03 18:00 statnews.com

STAT+: Baby KJ scientists hit road bump in quest to scale custom gene editor

gene editing FDA regulation custom therapies rare diseases manufacturing challenges Baby KJ

20/03 02:54 statnews.com

Political influence ‘a serious problem’ for FDA under Trump, former commissioner says

Robert Califf FDA political influence rare diseases gene therapies regulatory oversight

19/03 13:30 fortune.com

The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients

pharma drug repurposing shelved drugs biotech deals rare diseases innovation

19/03 13:30 fortune.com

The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients

pharma drug repurposing shelved drugs biotech deals rare diseases innovation

Loading...